Filing Details
- Accession Number:
- 0001209191-23-041333
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-07-05 19:33:03
- Reporting Period:
- 2023-06-30
- Accepted Time:
- 2023-07-05 19:33:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1759425 | Mirum Pharmaceuticals Inc. | MIRM | Pharmaceutical Preparations (2834) | 831281555 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1974200 | Jolanda Howe | C/O Mirum Pharmaceuticals, Inc. 950 Tower Lane, Suite 1050 Foster City CA 94404 | Svp, Global Controller | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2023-06-30 | 1,563 | $0.00 | 3,332 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2023-07-01 | 1,042 | $0.00 | 4,374 | No | 4 | M | Direct | |
Common Stock | Disposition | 2023-07-03 | 915 | $25.65 | 3,459 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Performance Restricted Stock Units | Disposition | 2023-06-30 | 1,563 | $0.00 | 1,563 | $0.00 |
Common Stock | Restricted Stock Units | Disposition | 2023-07-01 | 1,042 | $0.00 | 1,042 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | M | Direct | ||
2,083 | No | 4 | M | Direct |
Footnotes
- Each restricted stock unit represents a contingent right to receive one share of common stock (or its cash equivalent, at the discretion of the Issuer).
- Shares sold to cover tax withholding obligations associated with the vesting of restricted stock units.
- On March 9, 2021, the reporting person was granted performance-based restricted stock units ("PSUs"), which vest upon the satisfaction of certain performance criteria. On September 29, 2021, such performance criteria were met. 1,562 shares subject to the PSUs vested on September 29, 2021, and 1,563 shares vested on June 30, 2023.
- The restricted stock units vest in a series of three successive equal annual installments beginning July 1, 2023.